Hennion & Walsh Asset Management, Inc. Vertex Pharmaceuticals Inc Transaction History
Hennion & Walsh Asset Management, Inc.
- $1.89 Billion
- Q2 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 7,589 shares of VRTX stock, worth $3.73 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
7,589
Previous 7,006
8.32%
Holding current value
$3.73 Million
Previous $2.93 Million
21.48%
% of portfolio
0.19%
Previous 0.16%
Shares
8 transactions
Others Institutions Holding VRTX
# of Institutions
1,637Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12.6 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$11.1 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.9 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.49 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $126B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...